A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib

Echinoderm microtubule‐associated protein‐like 4‐anaplastic lymphoma kinase (EML4‐ALK) rearrangements are found in ~ 5% of patients with non‐small cell lung cancer (NSCLC). Several tyrosine kinase inhibitors (TKIs) have been developed for treatment of so‐called ALK‐positive NSCLC. In cases of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Yuki, Inomata, Sho, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Watanabe, Masayuki, Ozaki, Yuki, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Hasegawa, Takeo, Shio, Yutaka, Suzuki, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327688/
https://www.ncbi.nlm.nih.gov/pubmed/34159737
http://dx.doi.org/10.1111/1759-7714.14058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327688/
https://www.ncbi.nlm.nih.gov/pubmed/34159737
http://dx.doi.org/10.1111/1759-7714.14058

Ejemplares similares